MasterControl Launches Master Template Generator Beta for Life Sciences Manufacturing
New AI-powered feature helps regulated manufacturers streamline electronic batch record creation BERLIN, May 15, 2025 /PRNewswire/ — MasterControl, a leading... Read more.
Popular Space Strategy Game, Galactic Civilizations IV v3.0 Hyperlane Update Announced, Franchise Sale on Steam
The Turn-based space strategy game sees a revamp of galaxy generation, fleet management, computer AI, and much more PLYMOUTH, Mich., May 15, 2025 /PRNewswire/ —... Read more.
Globant Reports 2025 First Quarter Financial Results
First quarter revenues of $611.1 million, up 7.0% year-over-year IFRS Diluted EPS of $0.68 for the first quarter Non-IFRS Adjusted Diluted EPS of $1.50 for the first... Read more.
KORE Reports First Quarter 2025 Results
Growth in Connections, Operating Cash and Free Cash Flow ATLANTA, May 15, 2025 /PRNewswire/ — KORE Group Holdings, Inc. (NYSE: KORE) (“KORE”... Read more.
SOS Limited Reports 2024 Financial Results
SOS Limited Reports 92.6% Surge in Commodity Trading Revenue Amid Strategic Pivot Cryptocurrency Mining Revenue Halves as SOS Focuses on Facility Upgrades and Commodity... Read more.
AtWork Staffing Named to Forbes America’s Best Recruiting and Temporary Staffing Firms 2025 List
KNOXVILLE, Tenn., May 15, 2025 /PRNewswire/ — AtWork®, an award-winning leader in the staffing industry, is proud to announce its inclusion on the Forbes... Read more.
Rein Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
RENEW Phase 2 trial evaluating the safety, tolerability, and efficacy of LTI-03 in idiopathic pulmonary fibrosis (IPF) initiated with topline interim data expected... Read more.
LightPath Technologies Reports Third Quarter Fiscal 2025 Financial Results
ORLANDO, Fla., May 15, 2025 /PRNewswire/ — LightPath Technologies, Inc. (NASDAQ: LPTH) (“LightPath,” the “Company,” “we,”... Read more.
Docusign Announces Timing of First Quarter Fiscal 2026 Earnings Conference Call
SAN FRANCISCO, May 15, 2025 /PRNewswire/ — Docusign (Nasdaq: DOCU) today announced that its first quarter fiscal 2026 results will be released on Thursday,... Read more.
Neurocrine Biosciences Presents Data on Improvements in Physiologic Glucocorticoid Dosing and Select Reproductive Hormones in Patients with Classic Congenital Adrenal Hyperplasia Taking CRENESSITY™ (crinecerfont)
90% of Pediatric Participants on CRENESSITY versus 21% on Placebo Achieved ≥1 Threshold for Androstenedione Reduction or Glucocorticoid Reduction Observed Rates... Read more.